Add Company
Join Now

GEX Corporation Revenue and Competitors

License our Company Data API

Denver, CO USA

Location

N/A

Total Funding

Supplies

Industry

Employee Data

  • GEX Corporation has 17 Employees.(i)
  • GEX Corporation grew their employee count by 21% last year.

GEX Corporation's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director Customer ServicesReveal Email/Phone
3
Director Customer Support | System Support EngineerReveal Email/Phone
4
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M6716%N/AN/A
#2
$35M106-5%N/AN/A
#3
$35M41-2%N/AN/A
#4
N/A1721%N/AN/A
#5
$7.5M7519%N/AN/A
#6
$7.5M16-27%N/AN/A
#7
$75M4448%N/AN/A
#8
$7.5M3712%N/AN/A
#9
$7.5M32-3%N/AN/A
#10
$15M27-10%N/AN/A
Add Company

What Is GEX Corporation?

Since 1991, GEX has been providing dosimetry services and products for the radiation processing industry. We serve users of gamma, e-beam, and x-ray radiation process applications, such as medical device sterilization, surface sterilization, the curing of inks and coatings, and food irradiation. GEX is a single source for everything you will need for a successful dosimetry program: • Dosimetry Systems • Dosimeters • Equipment and System Accessories, • Software, • Procedures • Dosimeter Batch Calibrations • Customer Support • Expert Experience and Knowledge Our technical experts work with our customers in every aspect: from defining requirements, to implementation, to calibration, and to maintenance. All dosimetry solutions are dependent upon a customer’s particular application and the unique processing environment, and successful dosimetry involves the correct selection, implementation, and management of a comprehensive dose measurement system.

keywords:N/A

N/A

Total Funding

17

Number of Employees

N/A

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M1721%N/A
#2
$2.7M17-6%N/A
#3
$5.7M180%N/A
#4
N/A18-5%N/A
#5
$4.9M1919%N/A